GRAND RAPIDS – Venture capital investments in Midwest health sciences companies ballooned during the first half of 2016, both in terms of deal flow and dollar value.
Investors collectively put $1.04 billion into 218 deals involving Midwest-based health sciences companies between January and June, according to Cleveland-based BioEnterprise. That’s the largest amount and highest deal flow since BioEnterprise started tracking data in 2009. For comparison, investors put $507.8 million into 144 deals during the first half of 2015.
In Michigan, venture capital investors supported 15 deals with $116.4 million during the first half of 2016, which compares to seven deals for $15.2 million in the same period a year earlier.
The deal flow and investment value “puts the Midwest in a great position,” said BioEnterprise President and CEO Aram Nerpouni.
To read the rest of this story, click on https://mibiz.com/item/23923-michigan-health-sciences-firms-attract-?utm_source=newsletter_4406&utm_medium=email&utm_campaign=monday-morning-mibiz-michigan-vc-investing-spikes-in-health-sciences-firms
